By MICHAEL J. de la MERCEDAUG. 12, 2015
A swell of mergers and other transactions this year has bolstered the fortunes, and stock prices, of several independent and boutique investment banks.That has not necessarily translated into enthusiasm for another advisory firm seeking to join the public markets.Houlihan Lokey priced its initial public offering on Wednesday below expectations, raising $220 million in its stock sale. Its shares were offered at $21 each, a dollar below the expected range, and it sold fewer shares than initially anticipated.That stock price values the investment bank at about $1.4 billion.It is a disappointing start on the public markets for the 43-year-old firm, which like its boutique brethren focuses on advising on mergers, capital-raising efforts and corporate debt reorganizations. The firm also advises on shareholder activism situations, in which hedge funds and other investors publicly agitate for shifts in corporate strategy.AdvertisementWhat the boutique firm does not have — much like Moelis & Company, Evercore Partners or Greenhill & Company — are the big trading operations that larger competitors like Goldman Sachs and JPMorgan Chase run.Please verify you're not a robot by clicking the box.Invalid email address. Please re-enter.You must select a newsletter to subscribe to.View all New York Times newsletters.That model of independent advice has played well during a boom in deal making. And it has bolstered the stocks of some stand-alone firms, like Lazard and Evercore.AdvertisementThe investment bank will not collect any of the proceeds from the offering, since the selling investors are Orix, the Japanese conglomerate that controls the firm, and existing executives and directors.Houlihan Lokey is expected to begin trading on the New York Stock Exchange on Thursday under the ticker symbol HLI.The I.P.O. was led by Bank of America Merrill Lynch and Goldman Sachs.We’re interested in your feedback on this page. Tell us what you think.